MedPath

ToF-studieEmbryo transfer, day Three Or day Five, in good prognosis IVF cycles.

Completed
Conditions
Embryotransfer Day 3 vs Day 5In Vitro Fertilization(IVF)Cumulative live birth rateEmbryotransfer Dag 3 vs Dag 5In Vitro Fertilisatie(IVF)Cumulatief aantal levend geborenen
Registration Number
NL-OMON23649
Lead Sponsor
Radboud university medical center
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
1200
Inclusion Criteria

Women 18-42 years

IVF/ICSI treatment with more than 3 zygotes on culture day 1 available.

Exclusion Criteria

The use of testicular sperm extraction (TESE), Preimplantation genetic diagnosis (PGD)cycles The use of vitrified oocytes -Participating in interfering study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The primary aim is to study whether blastocyst stage embryo transfers (day 5) improves the cumulative LBR in IVF/ ICSI patients with a good prognosis (> 3 zygotes on day 1 after oocyte retrieval).
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath